The observed associations between R-RAS2, CD44, and Wnt receptors align with the higher R-RAS2 expression levels reported in postpartum TNBC cases, which are often associated with worse prognoses compared to other BC types and diagnoses in older or nulliparous women [35]. This evidence concerns the gene CD44 and breast cancer.